, Hong Kong
131 views
/Rawpixel from Envato

YF Life Insurance International faces challenges in new business margin

Fitch anticipates it will continue focusing on capital efficiency and product diversification.

YF Life Insurance International is seen to maintain its strong capitalisation levels, Fitch Ratings assessed. 

Its Hong Kong risk-based capital ratio stood at 234% in the third quarter, well above the regulatory minimum of 100%. 

Fitch anticipates the company will continue focusing on capital efficiency and product diversification whilst maintaining a debt-free capital structure.

Fitch also projects stable financial performance for YF Life, with return on equity averaging 6.4% over 2023 and the first half of 2024. 

However, the insurer faces challenges in its value of new business margin due to shifts in its product mix and heightened competition.

The company is expected to further reduce the duration mismatch between assets and liabilities to mitigate exposure to interest rate volatility. 

Fitch noted that liability duration has been lengthening faster than asset duration under declining interest rates, prompting YF Life to acquire long-term US-dollar bonds and bond-forwards to extend asset duration.

Investment risk remains low, with Fitch forecasting a continued conservative asset management approach. 
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.